ERCP术后并发肝包膜下血肿研究进展  

Advances in research on subcapsular hepatic hematoma after ERCP

作　　者：弓亚杰 张健康[2] GONG Yajie;ZHANG Jiankang(Shanxi Medical University,Taiyuan 030001;Department of Gastroenterology,the First Affiliated Hospital of Shanxi Medical University,China)

机构地区：[1]山西医科大学,山西太原030001 [2]山西医科大学第一附属医院消化内科

出　　处：《胃肠病学和肝病学杂志》2021年第3期347-351,共5页Chinese Journal of Gastroenterology and Hepatology

摘　　要：内镜逆行胆胰管造影术(endoscopic retrograde cholangiopancreatography,ERCP)是胆胰疾病诊断和治疗中最常用的方法之一。术后相关并发症发病率为0.8%~10%,死亡率为0.5%~1%。肝包膜下血肿(subcapsular hepatic hematoma)是一种较为罕见的ERCP术后并发症,但死亡率较高,故在ERCP术后并发症的鉴别诊断中极为重要。本文纳入了国内外最新文献,论述ERCP术后并发肝包膜下血肿的最新进展。Endoscopic retrograde cholangiopancreatography(ERCP)is one of the most commonly used procedures for the diagnosis and treatment of biliary-pancreatic disease.ERCP-related complications total around 0.8%to 10%,with a mortality rate ranging from 0.5%to 1%.Subcapsular hepatic hematoma after ERCP is a rare complication that must be taken into account in the differential diagnosis of symptomatic cases after ERCP for the high mortality.In this paper,the latest literatures were included to discuss the latest progress of ERCP complicated with hepatic subcapsular hematoma.

关 键 词：内镜逆行胆胰管造影术 并发症 肝包膜下血肿 

分 类 号：R575[医药卫生—消化系统] R576[医药卫生—内科学]